Newsletter Archive

  1. 05.14.24 -- Cell Counting Is Growing More Important Amid Advanced Therapy's Rise 5/14/2024
    05/14/24 Laboratory Network Newsletter
  2. 04.23.24 -- FDA Warns Industry Of Fraudulent & Unreliable Lab Testing Data In Premarket Submissions 4/23/2024
    04/23/24 Laboratory Network Newsletter
  3. 04.09.24 -- Pivoting To Allogeneic CAR-T Therapies With Celyad Oncology's CMO, Dr. Charlie Morris 4/9/2024
    04/09/24 Laboratory Network Newsletter
  4. 03.26.24 -- Notable Public Comments On The FDA's Proposed Regulation For Laboratory Developed Tests 3/26/2024
    03/26/24 Laboratory Network Newsletter
  5. 03.12.24 -- FDA's CBER Issues Final Guidance For CAR T Cell Products 3/12/2024
    03/12/24 Laboratory Network Newsletter